(DOW) Dow - NYSE
Sector: Basic Materials | Industry: Chemicals | Exchange: NYSE (USA) | Market Cap: 24.397m USD | Total Return: 13.5% in 12m
Avg Turnover: 406M
Qual. Beats: 2
Rev. Trend: -94.3%
Qual. Beats: 0
Warnings
High Debt/EBITDA (20.3) with thin interest coverage (-1.5)
High Debt while negative Cash Flow
Interest Coverage Ratio -1.5 is critical
Below Avwap Earnings
Tailwinds
No distinct edge detected
Dow Inc. is a global materials science company headquartered in Midland, Michigan, operating across three primary segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings. The company produces a wide range of chemical products, including polyethylene, polyurethanes, and silicones, which serve diverse end-markets such as food packaging, automotive manufacturing, and residential construction.
As a major player in the Commodity Chemicals sub-industry, Dow functions within a capital-intensive business model where profitability is often driven by global supply-demand balances and raw material costs, particularly natural gas and crude oil derivatives. The company maintains a highly integrated manufacturing structure, allowing it to convert basic hydrocarbons into high-value chemical building blocks across its international facility network.
For a deeper look into the companys fundamental health and valuation metrics, consider reviewing the latest data on ValueRay. Dows extensive portfolio also includes niche operations in property and casualty insurance, reflecting a complex corporate structure typical of large-scale industrial conglomerates.
- Feedstock cost volatility for ethane and propane impacts integrated margins
- Global demand for polyethylene packaging drives core revenue growth
- Construction sector downturn pressures industrial intermediates and coatings segments
- Energy price fluctuations in European markets affect manufacturing operating costs
- Strategic capital expenditure on net-zero emissions facilities influences long-term valuation
| Net Income: -2.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.47 > 1.0 |
| NWC/Revenue: 22.71% < 20% (prev 13.47%; Δ 9.24% < -1%) |
| CFO/TA 0.05 > 3% & CFO 2.81b > Net Income -2.76b |
| Net Debt (17.0b) to EBITDA (840.0m): 20.25 < 3 |
| Current Ratio: 1.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (721.2m) vs 12m ago 2.02% < -2% |
| Gross Margin: 6.16% > 18% (prev 8.91%; Δ -2.75% > 0.5%) |
| Asset Turnover: 67.07% > 50% (prev 74.14%; Δ -7.07% > 0%) |
| Interest Coverage Ratio: -1.51 > 6 (EBIT TTM -1.33b / Interest Expense TTM 881.0m) |
| A: 0.15 (Total Current Assets 19.5b - Total Current Liabilities 10.5b) / Total Assets 59.8b |
| B: 0.27 (Retained Earnings 16.0b / Total Assets 59.8b) |
| C: -0.02 (EBIT TTM -1.33b / Avg Total Assets 58.6b) |
| D: 0.35 (Book Value of Equity 15.2b / Total Liabilities 43.0b) |
| Altman-Z'' = 2.07 = BBB |
| DSRI: 1.12 (Receivables 7.41b/7.18b, Revenue 39.3b/42.6b) |
| GMI: 1.45 (GM 8.91% / 6.16%) |
| AQI: 1.00 (AQ_t 0.30 / AQ_t-1 0.30) |
| SGI: 0.92 (Revenue 39.3b / 42.6b) |
| TATA: -0.09 (NI -2.76b - CFO 2.81b) / TA 59.8b) |
| Beneish M = -2.59 (Cap -4..+1) = A |
As of June 17, 2026, the stock is trading at USD 32.96 with a total of 8,060,663 shares traded.
Over the past week, the price has changed by -0.78%,
over one month by -13.65%,
over three months by -7.51% and
over the past year by +13.46%.
Dow has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold DOW.
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 42.3 | 28.2% |
P/E Forward = 11.5075
P/S = 0.6203
P/B = 1.5999
P/EG = 38.8911
Revenue TTM = 39.3b USD
EBIT TTM = -1.33b USD
EBITDA TTM = 840.0m USD
Long Term Debt = 17.3b USD (from longTermDebt, last quarter)
Short Term Debt = 1.23b USD (from shortTermDebt, last quarter)
Debt = 21.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.49b
Net Debt = 17.0b USD (calculated: Debt 21.1b - CCE 4.11b)
Enterprise Value = 41.4b USD (24.4b + Debt 21.1b - CCE 4.11b)
Interest Coverage Ratio = -1.51 (Ebit TTM -1.33b / Interest Expense TTM 881.0m)
EV/FCF = -29.68x (Enterprise Value 41.4b / FCF TTM -1.40b)
FCF Yield = -3.37% (FCF TTM -1.40b / Enterprise Value 41.4b)
FCF Margin = -3.55% (FCF TTM -1.40b / Revenue TTM 39.3b)
Net Margin = -7.02% (Net Income TTM -2.76b / Revenue TTM 39.3b)
Gross Margin = 6.16% ((Revenue TTM 39.3b - Cost of Revenue TTM 36.9b) / Revenue TTM)
Gross Margin QoQ = 6.53% (prev 5.79%)
Tobins Q-Ratio = 0.69 (Enterprise Value 41.4b / Total Assets 59.8b)
Interest Expense / Debt = 4.17% (Interest Expense 881.0m / Debt 21.1b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -1.05b (EBIT -1.33b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.85 (Total Current Assets 19.5b / Total Current Liabilities 10.5b)
Debt / Equity = 1.39 (Debt 21.1b / totalStockholderEquity, last quarter 15.2b)
Debt / EBITDA = 20.25 (Net Debt 17.0b / EBITDA 840.0m)
Debt / FCF = -12.20 (negative FCF - burning cash) (Net Debt 17.0b / FCF TTM -1.40b)
Total Stockholder Equity = 16.5b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.71% (Net Income -2.76b / Total Assets 59.8b)
RoE = -16.73% (Net Income TTM -2.76b / Total Stockholder Equity 16.5b)
RoCE = -3.93% (EBIT -1.33b / Capital Employed (Equity 16.5b + L.T.Debt 17.3b))
RoIC = -2.16% (negative operating profit) (NOPAT -1.05b / Invested Capital 48.5b)
WACC = 6.15% (E(24.4b)/V(45.5b) * Re(8.63%) + D(21.1b)/V(45.5b) * Rd(4.17%) * (1-Tc(0.21)))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 65.93 | Cagr: 1.10%
[DCF] Fair Price = unknown (Cash Flow -1.40b)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.85 | # QB: 2
Revenue Correlation: -94.34 | Revenue CAGR: -6.17% | SUE: 0.83 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.22 | Chg30d=+3.15% | Revisions=+0% | Analysts=13
EPS next Quarter (2026-09-30): EPS=1.21 | Chg30d=+3.63% | Revisions=+33% | Analysts=11
EPS current Year (2026-12-31): EPS=3.01 | Chg30d=+4.04% | Revisions=+43% | GrowthEPS=+419.9% | GrowthRev=+13.0%
EPS next Year (2027-12-31): EPS=2.18 | Chg30d=+5.32% | Revisions=+14% | GrowthEPS=-27.5% | GrowthRev=+0.9%
[Analyst] Revisions Ratio: +43%